Today: 7 February 2026
Subscribe

Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Vertex Pharmaceuticals shares rose 4.31% to $461.14, extending gains for a third session with trading volume above the 50-day average. The company will report fourth-quarter and full-year 2025 results after the U.S. market closes on Feb. 12, followed by a conference call. Director Bruce I. Sachs received 107.088 deferred stock units, according to a Jan. 15 regulatory filing.
22 January 2026
···
FedEx stock gets a tug-of-war: downgrade meets $350–$355 targets as freight spin-off looms

FedEx stock gets a tug-of-war: downgrade meets $350–$355 targets as freight spin-off looms

Rothschild Redburn downgraded FedEx to Neutral and raised its price target to $317, citing the planned freight spin-off. Argus and Wolfe Research lifted their FedEx price targets to $350 and $355, respectively, while maintaining positive ratings. FedEx shares closed at $306.95, about 3.7% below their 52-week high. The company aims to complete the FedEx Freight spin-off by June 1, 2026.
22 January 2026
·
Beazley Rejects Zurich’s $10bn Takeover Bid as Lloyd’s Plan B Takes Shape

Beazley Rejects Zurich’s $10bn Takeover Bid as Lloyd’s Plan B Takes Shape

Beazley’s board rejected Zurich Insurance’s £8.4 billion all-cash bid at 1,280p per share, calling it a “material undervaluation.” Beazley shares dropped about 3% after the announcement. Zurich faces a UK deadline to confirm or withdraw its offer and is preparing a Lloyd’s syndicate as an alternative entry into the market. Beazley urged shareholders to wait for full-year results due March 4.
22 January 2026
·
Moderna stock (MRNA) steadies in premarket after 16% surge on Merck cancer-vaccine data

Moderna stock (MRNA) steadies in premarket after 16% surge on Merck cancer-vaccine data

Moderna shares held steady at $49.81 premarket Thursday after surging 15.8% on five-year melanoma data for its cancer vaccine with Merck. The vaccine-Keytruda combo cut recurrence or death risk by 49% versus Keytruda alone. U.S. vaccine-policy uncertainty is adding risk for the sector. Investors await Moderna’s Feb. 13 earnings call for updates on oncology data and 2026 sales.
22 January 2026
··
Diageo share price climbs in London as Barclays, Jefferies stick with Buy calls ahead of Feb 25 results

Diageo share price climbs in London as Barclays, Jefferies stick with Buy calls ahead of Feb 25 results

Diageo shares rose 0.5% in early London trading Thursday after a 2.6% gain the previous day, though the stock remains down 31% over the past year. The company reaffirmed its 2026 outlook, expecting flat or slightly lower organic net sales and low-to-mid single-digit profit growth. United Spirits, Diageo’s Indian arm, reported a 12% profit jump on strong premium sales. Interim results are due Feb. 25.
22 January 2026
·
LSEG share price dips in early London trade after fresh buyback update — here’s what investors are watching

LSEG share price dips in early London trade after fresh buyback update — here’s what investors are watching

London Stock Exchange Group shares slipped 0.5% to 8,736 pence by mid-morning Thursday after announcing a fresh buyback. The move followed a 2.2% drop Wednesday, underperforming the FTSE 100. Deutsche Boerse’s 5.35 billion euro Allfunds deal kept sector M&A in focus. Investors await the Bank of England’s Feb. 5 meeting and LSEG’s full-year results on Feb. 26.
22 January 2026
··
Lloyds shares are above £1 again — UBS lifts target as investors do the dividend maths

Lloyds shares are above £1 again — UBS lifts target as investors do the dividend maths

Lloyds shares rose 1.8% to 103.25p in early London trading, surpassing the £1 mark ahead of full-year results due Jan. 29. UBS raised its price target to 103p but kept a neutral rating, citing post-2026 growth uncertainty. Analyst consensus puts the 12-month target at 101.11p, below the current price. Retail investors are watching for dividend prospects, with forecasts suggesting only modest gains.
22 January 2026
··
GSK share price steadies as $2.2bn RAPT deal lands amid fresh U.S. vaccine-policy risk

GSK share price steadies as $2.2bn RAPT deal lands amid fresh U.S. vaccine-policy risk

GSK shares rose 0.1% in early London trading as investors assessed the $2.2 billion acquisition of RAPT Therapeutics and changes to ViiV Healthcare’s ownership. The deal brings ozureprubart, a mid-stage food-allergy drug, into GSK’s pipeline. Pfizer will exit ViiV, with Shionogi raising its stake to 21.7%. Uncertainty over U.S. vaccine policy clouds the outlook ahead of GSK’s Feb. 4 results.
22 January 2026
···
Rolls-Royce shares rebound after a wobble as investors size up the 2026 trade

Rolls-Royce shares rebound after a wobble as investors size up the 2026 trade

Rolls-Royce shares rose 0.8% to 1,264.5 pence in early London trading Thursday, rebounding from a 2% drop the previous day. The company began a £200 million interim share buyback on Jan. 2, set to finish before full-year results on Feb. 26. Analysts cite defence spending and profit targets but warn valuations are high. Rolls-Royce moved from £5.16 billion net debt in 2021 to £1.08 billion net cash by June 2025.
22 January 2026
Barclays snaps up 2.5 million more shares as buyback presses on amid tariff volatility

Barclays snaps up 2.5 million more shares as buyback presses on amid tariff volatility

Barclays bought back 2,522,940 shares on Jan. 21 at an average price of 475.07 pence, bringing total repurchases since October to 86,403,909 shares. All repurchased shares will be cancelled, reducing the bank’s share capital to 13.83 billion ordinary shares. The buybacks come amid renewed tariff disputes and geopolitical tensions affecting markets. NatWest also repurchased 830,691 shares for cancellation on Wednesday.
22 January 2026
··
1 … 274 275 276 277 278 … 1,634

Stock Market Today

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

7 February 2026
Coca-Cola will discontinue its frozen products, including the Minute Maid frozen line, in the U.S. and Canada in Q1 2026. Shares closed Friday up 0.66% at $79.03 ahead of Tuesday’s quarterly results. CEO James Quincey sold 337,824 shares on Feb. 3 for about $26 million under a pre-arranged plan. Options pricing suggests a possible 3% move after earnings.
Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

7 February 2026
Cisco shares closed up 3% at $84.82 Friday after a volatile week for tech stocks. The company will report quarterly results Feb. 11, with analysts expecting EPS of $1.02 on $15.12 billion revenue. U.S. jobs and inflation data, delayed by the federal shutdown, are also due next week. About 23.9 million Cisco shares traded Friday.
Go toTop